Fludeoxyglucose f18
HealthData.Gov
Updated Mar 25, 2026
About this dataset
Fludeoxyglucose F18 is a radioactive diagnostic agent used in positron emission tomography (PET) scans to help detect and evaluate conditions like cancer. It's administered intravenously as an injection, with a strength of up to 300 mCi/mL. Manufactured by MIPS Cyclotron & Radiochemistry Facility, it's a prescription drug approved as a generic equivalent. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Fludeoxyglucose f18
Access the FDA dataset for Fludeoxyglucose f18 — ANDA 203308 submitted by Mylan Institutional LLC
Modified Mar 24, 2026